Calcium folinate pentahydrate
Appendiceal Cancer
University of UtahSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Appendiceal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CIS-DIAMMINEDICHLOROPLATINUM II National Cancer Institute (NCI) | Phase 2 | BB |
Irinotecan University Hospital, Ghent | Phase 2 | BB |
MITOMYCIN C National Cancer Institute (NCI) | Phase 2 | B |
Sodium Thiosulfate National Cancer Institute (NCI) | Phase 2 | B |
Nilotinib National Cancer Institute (NCI) | Phase 2 | B |
View all 13 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →